NTRA Natera, Inc.
$328.93
Natera, Inc. (NTRA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran below NTRA's own trailing one-year pace, with 84% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
9 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
11
230 transactions
Purchases
$0
0 shares
Sales
$121.6M
496,497 shares
Net activity
-$121.6M
purchases less sales
How much of that selling was preplanned? 84% planned / 16% discretionary
10b5-1 plan sales
$102.0M
220 transactions · 407,497 shares
Discretionary sales
$19.6M
10 transactions · 89,000 shares
Largest single sale: $5.9M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Rabinowitz Matthew 6 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $327.97 | $16.4M | 2,274,594 −2.2% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 15,160 | $326.89 | $5.0M | 110,859 −12% of holding | |
| Moshkevich Solomon 3 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,000 | $320.73 | $962.2K | 128,019 −2.3% of holding | |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell 10b5-1 | 1,698 | $320.99 | $545.0K | 98,199 −1.7% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 6,517 | $321.53 | $2.1M | 197,257 −3.2% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 6,000 | $325.32 | $2.0M | 230,464 −2.5% of holding | |
| Sheena Jonathan 10 fills | Director | Sell 10b5-1 | 9,150 | $315.66 | $2.9M | 245,514 −3.6% of holding | |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 2,000 | $320.90 | $641.8K | 2,000 −50% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 478 | $274.22 | $131.1K | 51,637 −0.9% of holding | |
| Moshkevich Solomon 7 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,410 | $265.58 | $905.6K | 132,019 −2.5% of holding | |
| Chapman Steven Leonard 7 fills | CEO AND PRESIDENT | Sell 10b5-1 | 3,076 | $266.39 | $819.4K | 101,791 −2.9% of holding | |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 731 | $267.99 | $195.9K | 2,275,394 −0% of holding | |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 334 | $267.99 | $89.5K | 170,073 −0.2% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 317 | $267.99 | $85.0K | 52,115 −0.6% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 295 | $267.99 | $79.1K | 183,774 −0.2% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 109 | $267.99 | $29.2K | 245,614 −0% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 1,863 | $249.38 | $464.6K | 52,432 −3.4% of holding | |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell 10b5-1 | 3,580 | $254.07 | $909.6K | 102,973 −3.4% of holding | |
| Brophy Michael Burkes 3 fills | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 2,419 | $253.96 | $614.3K | 55,473 −4.2% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 1,204 | $254.07 | $305.9K | 132,429 −0.9% of holding | |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 1,003 | $254.07 | $254.8K | 170,407 −0.6% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 931 | $254.07 | $236.5K | 184,069 −0.5% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 191 | $254.07 | $48.5K | 245,723 −0.1% of holding | |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell 10b5-1 | 2,190 | $260.49 | $570.5K | 106,553 −2% of holding | |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 1,718 | $260.49 | $447.5K | 2,276,125 −0.1% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 1,010 | $260.49 | $263.1K | 133,633 −0.8% of holding | |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 884 | $260.49 | $230.3K | 171,410 −0.5% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 782 | $260.49 | $203.7K | 185,000 −0.4% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 782 | $260.49 | $203.7K | 56,714 −1.4% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 288 | $260.49 | $75.0K | 245,914 −0.1% of holding | |
| Sheena Jonathan 8 fills | Director | Sell 10b5-1 | 1,500 | $273.88 | $410.8K | 18,392 −7.5% of holding | |
| Chapman Rowan E | Director | Sell 10b5-1 | 135 | $274.82 | $37.1K | 4,663 −2.8% of holding | |
| Sheena Jonathan 6 fills | Director | Sell 10b5-1 | 3,150 | $265.68 | $836.9K | 248,852 −1.2% of holding | |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 1,000 | $280.00 | $280.0K | 4,000 −20% of holding | |
| RABINOWITZ DANIEL 12 fills | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 16,800 | $272.29 | $4.6M | 187,526 −8.2% of holding | |
| Moshkevich Solomon 3 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,000 | $272.90 | $818.7K | 137,543 −2.1% of holding | |
| RABINOWITZ DANIEL 4 fills | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 33,600 | $251.65 | $8.5M | 206,490 −14% of holding | |
| ROSENMAN HERM | Director | Sell 10b5-1 | 16,530 | $250.00 | $4.1M | 4,250 −79.5% of holding | |
| Sheena Jonathan 9 fills | Director | Sell 10b5-1 | 1,500 | $219.87 | $329.8K | 19,276 −7.2% of holding | |
| Chapman Rowan E | Director | Sell 10b5-1 | 2,964 | $216.78 | $642.5K | 3,124 −48.7% of holding | |
| Rabinowitz Matthew 10 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $214.91 | $10.7M | 2,327,012 −2.1% of holding | |
| Sheena Jonathan 4 fills | Director | Sell 10b5-1 | 3,150 | $211.14 | $665.1K | 250,752 −1.2% of holding | |
| Rabinowitz Matthew 11 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $214.03 | $10.7M | 2,375,307 −2.1% of holding | |
| Marcus Gail Boxer 4 fills | Director | Sell | 11,000 | $217.21 | $2.4M | 14,167 −43.7% of holding | |
| Chapman Steven Leonard 14 fills | CEO AND PRESIDENT | Sell 10b5-1 | 41,124 | $221.03 | $9.1M | 149,035 −21.6% of holding | |
| BOTHA ROELOF 6 fills | Director | Sell | 78,000 | $220.31 | $17.2M | 1,127,787 −6.5% of holding | |
| Moshkevich Solomon 4 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,000 | $218.43 | $655.3K | 138,841 −2.1% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 1,652 | $202.84 | $335.1K | 140,643 −1.2% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 1,438 | $202.84 | $291.7K | 185,782 −0.8% of holding | |
| Sheena Jonathan 8 fills | Director | Sell 10b5-1 | 1,500 | $201.56 | $302.3K | 20,197 −6.9% of holding | |
| Sheena Jonathan 5 fills | Director | Sell 10b5-1 | 3,150 | $208.60 | $657.1K | 255,452 −1.2% of holding | |
| Rabinowitz Matthew 4 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 6,986 | $213.77 | $1.5M | 2,379,553 −0.3% of holding | |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 722 | $206.16 | $148.8K | 2,382,440 −0% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 482 | $210.49 | $101.5K | 57,496 −0.8% of holding | |
| Moshkevich Solomon 7 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,405 | $203.69 | $693.6K | 145,295 −2.3% of holding | |
| Chapman Steven Leonard | CEO AND PRESIDENT | Sell 10b5-1 | 902 | $206.16 | $186.0K | 149,867 −0.6% of holding | |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 330 | $206.16 | $68.0K | 222,694 −0.1% of holding | |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 313 | $206.16 | $64.5K | 57,978 −0.5% of holding | |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 291 | $206.16 | $60.0K | 187,220 −0.2% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 107 | $206.16 | $22.1K | 255,652 −0% of holding | |
| Sheena Jonathan 2 fills | Director | Sell 10b5-1 | 3,071 | $196.42 | $603.2K | 256,516 −1.2% of holding | |
| Brophy Michael Burkes 5 fills | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 3,070 | $193.74 | $594.8K | 61,061 −4.8% of holding | |
| Chapman Steven Leonard 2 fills | CEO AND PRESIDENT | Sell 10b5-1 | 5,838 | $204.14 | $1.2M | 154,335 −3.6% of holding | |
| Moshkevich Solomon 2 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 2,182 | $204.10 | $445.3K | 146,885 −1.5% of holding | |
| Brophy Michael Burkes 2 fills | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 1,993 | $204.14 | $406.9K | 62,583 −3.1% of holding | |
| RABINOWITZ DANIEL 2 fills | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 1,861 | $204.09 | $379.8K | 224,012 −0.8% of holding | |
| Fesko John 2 fills | PRESIDENT, CHIEF BUS. OFFICER | Sell 10b5-1 | 1,688 | $204.10 | $344.5K | 188,428 −0.9% of holding | |
| Sheena Jonathan 2 fills | Director | Sell 10b5-1 | 473 | $204.00 | $96.5K | 258,970 −0.2% of holding | |
| Sheena Jonathan 2 fills | Director | Sell 10b5-1 | 1,500 | $199.63 | $299.4K | 20,282 −6.9% of holding | |
| RABINOWITZ DANIEL 5 fills | SEC. AND CHIEF LEGAL OFFICER | Sell 10b5-1 | 8,400 | $203.31 | $1.7M | 232,985 −3.5% of holding | |
| Moshkevich Solomon 3 fills | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 3,000 | $202.30 | $606.9K | 149,834 −2% of holding | |
| Sheena Jonathan 6 fills | Director | Sell 10b5-1 | 1,500 | $199.95 | $299.9K | 21,547 −6.5% of holding | |
| Sheena Jonathan 3 fills | Director | Sell 10b5-1 | 3,070 | $198.17 | $608.4K | 262,025 −1.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.